Your search returned 29 results.

Results
	21.	The BCR-ABL1 T315I mutation and additional genomic aberrations are dominant genetic lesions associated with disease progression in patients with chronic myelogenous leukemia resistant to tyrosine kinase inhibitor therapy. [electronic resource] by Malcikova, Jitka Razga, Filip Jurcek, Tomas Dvorakova, Dana Zackova, Daniela Toskova, Martina Sebejova, Ludmila Smardova, Jana Oltova, Alexandra Vankova, Gabriela Jurackova, Lenka Trbusek, Martin Pospisilova, Sarka Mayer, Jiri Racil, Zdenek Producer: 20140306 In: Leukemia & lymphoma vol. 54 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	22.	Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy. [electronic resource] by Racil, Zdenek Koritakova, Eva Sacha, Tomasz Klamova, Hana Belohlavkova, Petra Faber, Edgar Rea, Delphine Malaskova, Ludmila Prochazkova, Jirina Zackova, Daniela Voglova, Jaroslava Wącław, Joanna Cetkovsky, Petr Zak, Pavel Mayer, Jiri Producer: 20190627 In: American journal of hematology vol. 93 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	23.	No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia. [electronic resource] by Racil, Zdenek Razga, Filip Klamova, Hana Voglova, Jaroslava Belohlavkova, Petra Malaskova, Ludmila Potesil, David Muzik, Jan Zackova, Daniela Polakova, Katerina Machova Zdrahal, Zbynek Malakova, Jana Suttnar, Jiri Dyr, Jan Mayer, Jiri Producer: 20140930 In: Hematological oncology vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	24.	Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects. [electronic resource] by Culen, Martin Borsky, Marek Nemethova, Veronika Razga, Filip Smejkal, Jiri Jurcek, Tomas Dvorakova, Dana Zackova, Daniela Weinbergerova, Barbora Semerad, Lukas Sadovnik, Irina Eisenwort, Gregor Herrmann, Harald Valent, Peter Mayer, Jiri Racil, Zdenek Producer: 20180212 In: Oncotarget vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	25.	Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: can we compare real life data to the results from clinical trials? [electronic resource] by Zackova, Daniela Klamova, Hana Dusek, Ladislav Muzik, Jan Polakova, Katerina Machova Moravcova, Jana Jurcek, Tomas Dvorakova, Dana Racil, Zdenek Pospisil, Zdenek Oltova, Alexandra Michalova, Kyra Brezinova, Jana Razga, Filip Doubek, Michael Cetkovsky, Petr Trneny, Marek Mayer, Jiri Producer: 20110506 In: American journal of hematology vol. 86 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	26.	Treatment of chronic myeloid leukemia with autologous transplantation using peripheral blood stem cells or bone marrow cultured in IL-2 followed by IL-2, GM-CSF, and IFN-alpha administration. [electronic resource] by Hájek, Roman Zácková, Daniela Büchler, Tomás Penka, Miroslav Krahulcová, Eva Korístek, Zdenĕk Vinklárková, Jaroslava Adler, Jiri Janovská, Eva Indrák, Karel Faber, Edgar Doubek, Michal Klabusay, Martin Oltová, Alexandra Kuglík, Petr Bourková, Ludmila Dusek, Ladislav Mareschová, Iveta Mayer, Jiri Vorlícek, Jiri Producer: 20031023 In: Medical oncology (Northwood, London, England) vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	27.	Current survival measures reliably reflect modern sequential treatment in CML: correlation with prognostic stratifications. [electronic resource] by Pavlik, Tomas Janousova, Eva Mayer, Jiri Indrak, Karel Jarosova, Marie Klamova, Hana Zackova, Daniela Voglova, Jaroslava Faber, Edgar Karas, Michal Machova Polakova, Katerina Racil, Zdenek Demeckova, Eva Demitrovicova, Ludmila Tothova, Elena Chudej, Juraj Markuljak, Imrich Cmunt, Eduard Kozak, Tomas Muzik, Jan Dusek, Ladislav Producer: 20131029 In: American journal of hematology vol. 88 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	28.	Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin. [electronic resource] by Lauseker, Michael Bachl, Katharina Turkina, Anna Faber, Edgar Prejzner, Witold Olsson-Strömberg, Ulla Baccarani, Michele Lomaia, Elza Zackova, Daniela Ossenkoppele, Gert Griskevicius, Laimonas Schubert-Fritschle, Gabriele Sacha, Tomasz Heibl, Sonja Koskenvesa, Perttu Bogdanovic, Andrija Clark, Richard E Guilhot, Joelle Hoffmann, Verena S Hasford, Joerg Hochhaus, Andreas Pfirrmann, Markus Producer: 20200326 In: American journal of hematology vol. 94 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	29.	Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels. [electronic resource] by Klamová, Hana Poláková, Kateřina Machová Mužík, Jan Ráčil, Zdeněk Záčková, Daniela Steinerová, Kateřina Karas, Michal Faber, Edgar Demečková, Eva Michalovičová-Sninská, Zuzana Voglová, Jaroslava Demitrovičová, Ludmila Mikušková, Eva Tóthová, Elena Chudej, Juraj Markuljak, Imrich Cmunt, Eduard Moravcová, Jana Dvořáková, Dana Michalová, Kyra Jarošová, Marie Sťastná, Markéta Marková Cetkovský, Petr Dušek, Ladislav Koza, Vladimír Trněný, Marek Indrák, Karel Producer: 20140207 In: Cancer medicine vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)